DE60217390D1 - Bicalutamid enthaltende pharmazeutische zusammensetzung - Google Patents

Bicalutamid enthaltende pharmazeutische zusammensetzung

Info

Publication number: DE60217390D1
Authority: DE; Germany
Prior art keywords: bicalutamide; pharmaceutical composition; containing pharmaceutical; composition; pharmaceutical
Prior art date: 2001-11-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60217390T

Other languages

English (en)

Other versions

DE60217390T2 (de

Inventor

Frances Bateman

Kay Cahill

Hugh Carman

Derek Cockshott

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

AstraZeneca UK Ltd

Original Assignee

AstraZeneca UK Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-16

Filing date

2002-11-14

Publication date

2007-02-15

2002-11-14 Application filed by AstraZeneca UK Ltd filed Critical AstraZeneca UK Ltd

2007-02-15 Application granted granted Critical

2007-02-15 Publication of DE60217390D1 publication Critical patent/DE60217390D1/de

2007-11-15 Publication of DE60217390T2 publication Critical patent/DE60217390T2/de

2022-11-15 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

DE60217390T 2001-11-16 2002-11-14 Bicalutamid enthaltende pharmazeutische zusammensetzung Expired - Fee Related DE60217390T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0103839A SE0103839D0 (sv)	2001-11-16	2001-11-16	Pharmaceutical formulation & product
SE0103839		2001-11-16
PCT/GB2002/005159 WO2003043606A1 (en)	2001-11-16	2002-11-14	Pharmaceutical formulation comprising bicalutamide

Publications (2)

Publication Number	Publication Date
DE60217390D1 true DE60217390D1 (de)	2007-02-15
DE60217390T2 DE60217390T2 (de)	2007-11-15

Family

ID=20286023

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60217390T Expired - Fee Related DE60217390T2 (de)	2001-11-16	2002-11-14	Bicalutamid enthaltende pharmazeutische zusammensetzung

Country Status (20)

Country	Link
US (1)	US20050038111A1 (de)
EP (1)	EP1448168B1 (de)
JP (1)	JP2005514355A (de)
KR (1)	KR20050044468A (de)
CN (1)	CN1615122A (de)
AR (1)	AR037390A1 (de)
AT (1)	ATE350016T1 (de)
AU (1)	AU2002343024A1 (de)
BR (1)	BR0214135A (de)
CA (1)	CA2466986A1 (de)
DE (1)	DE60217390T2 (de)
ES (1)	ES2278063T3 (de)
IL (1)	IL161902A0 (de)
MX (1)	MXPA04004591A (de)
NO (1)	NO20042502L (de)
SE (1)	SE0103839D0 (de)
TW (1)	TW200406200A (de)
UY (1)	UY27539A1 (de)
WO (1)	WO2003043606A1 (de)
ZA (1)	ZA200403689B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK10722003A3 (sk) *	2001-02-27	2004-02-03	Astrazeneca Ab	Farmaceutická formulácia obsahujúca bicalutamid v pevnej disperzii s enterickým polymérom a jej použitie
US7524866B2 (en)	2001-11-29	2009-04-28	Gtx, Inc.	Prevention and treatment of androgen—deprivation induced osteoporosis
US7332525B2 (en) *	2003-01-17	2008-02-19	Castle Erik P	Method of treatment of prostate cancer and composition for treatment thereof
US7226622B2 (en)	2003-09-18	2007-06-05	Boston Scientific Scimed, Inc.	Chemoablation of tissue using biodegradable, solid salt dosage forms
NZ548670A (en) *	2004-01-28	2010-05-28	Androscience Corp	Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof
RU2007106036A (ru) *	2004-08-31	2008-10-10	Пфайзер Продактс Инк. (Us)	Антитело к cd40: препарат и способы
GB0424339D0 (en) *	2004-11-03	2004-12-08	Astrazeneca Ab	Combination therapy
JP2008531531A (ja) *	2005-02-23	2008-08-14	アストラゼネカアクチボラグ	方法
JP2008534575A (ja) *	2005-03-29	2008-08-28	ユーエスヴィーリミテッド	ビカルタミドの調製のための新規プロセス
US20090291134A1 (en) *	2006-11-21	2009-11-26	Jina Pharmaceuticals, Inc.	Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
AU2009215799B2 (en) *	2008-02-21	2013-08-22	Iris International Inc.	Method for early determination of recurrence after therapy for prostate cancer
CA2737528A1 (en) *	2008-09-17	2010-03-25	Mylan Laboratories, Inc.	Granulates, process for preparing them and pharmaceutical products containing them
SI3725778T1 (sl)	2012-09-11	2022-02-28	Medivation Prostate Therapeutics Llc	Formulacije enzalutamida
CN107049972A (zh) *	2017-03-17	2017-08-18	万特制药(海南)有限公司	一种含有来曲唑固体分散体的分散片及其制备工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3121152A1 (de) *	1981-05-22	1982-12-09	Schering Ag, 1000 Berlin Und 4619 Bergkamen	"verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie"
US4895715A (en) *	1988-04-14	1990-01-23	Schering Corporation	Method of treating gynecomastia
CA2181358A1 (en) *	1994-01-21	1995-07-27	Nancy M. Gray	Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
GB9707800D0 (en) *	1996-05-06	1997-06-04	Zeneca Ltd	Chemical compounds
US6139875A (en) *	1998-09-29	2000-10-31	Eastman Chemical Company	Aqueous enteric coating composition and low gastric permeability enteric coating

2001
- 2001-11-16 SE SE0103839A patent/SE0103839D0/xx unknown
2002
- 2002-10-31 TW TW091132270A patent/TW200406200A/zh unknown
- 2002-11-13 UY UY27539A patent/UY27539A1/es not_active Application Discontinuation
- 2002-11-14 IL IL16190202A patent/IL161902A0/xx unknown
- 2002-11-14 ES ES02779684T patent/ES2278063T3/es not_active Expired - Lifetime
- 2002-11-14 AU AU2002343024A patent/AU2002343024A1/en not_active Abandoned
- 2002-11-14 MX MXPA04004591A patent/MXPA04004591A/es unknown
- 2002-11-14 US US10/495,012 patent/US20050038111A1/en not_active Abandoned
- 2002-11-14 AT AT02779684T patent/ATE350016T1/de not_active IP Right Cessation
- 2002-11-14 CA CA002466986A patent/CA2466986A1/en not_active Abandoned
- 2002-11-14 DE DE60217390T patent/DE60217390T2/de not_active Expired - Fee Related
- 2002-11-14 EP EP02779684A patent/EP1448168B1/de not_active Expired - Lifetime
- 2002-11-14 WO PCT/GB2002/005159 patent/WO2003043606A1/en active IP Right Grant
- 2002-11-14 CN CNA028272277A patent/CN1615122A/zh active Pending
- 2002-11-14 JP JP2003545287A patent/JP2005514355A/ja not_active Withdrawn
- 2002-11-14 KR KR1020047007359A patent/KR20050044468A/ko not_active Application Discontinuation
- 2002-11-14 AR ARP020104386A patent/AR037390A1/es unknown
- 2002-11-14 BR BR0214135-3A patent/BR0214135A/pt not_active Application Discontinuation
2004
- 2004-05-13 ZA ZA200403689A patent/ZA200403689B/en unknown
- 2004-06-15 NO NO20042502A patent/NO20042502L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1448168B1 (de)	2007-01-03
KR20050044468A (ko)	2005-05-12
ATE350016T1 (de)	2007-01-15
ES2278063T3 (es)	2007-08-01
AU2002343024A1 (en)	2003-06-10
MXPA04004591A (es)	2004-08-13
UY27539A1 (es)	2003-07-31
CA2466986A1 (en)	2003-05-30
JP2005514355A (ja)	2005-05-19
BR0214135A (pt)	2004-10-13
DE60217390T2 (de)	2007-11-15
TW200406200A (en)	2004-05-01
US20050038111A1 (en)	2005-02-17
WO2003043606A1 (en)	2003-05-30
NO20042502L (no)	2004-08-09
IL161902A0 (en)	2005-11-20
ZA200403689B (en)	2006-06-28
EP1448168A1 (de)	2004-08-25
AR037390A1 (es)	2004-11-10
SE0103839D0 (sv)	2001-11-16
CN1615122A (zh)	2005-05-11

Legal Events

Date	Code	Title	Description
2008-01-24	8364	No opposition during term of opposition
2009-09-17	8339	Ceased/non-payment of the annual fee

Publication	Publication Date	Title
DE60127002D1 (de)	2007-04-12	Pharmazeutische zusammensetzung
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
NO20033384D0 (no)	2003-07-29	Farmasöytisk formulering
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
ATE334656T1 (de)	2006-08-15	Flüssige pharmazeutische zusammensetzung
ATE307571T1 (de)	2005-11-15	Pharmazeutische formulierung enthaltend bicalutamid
AT7729U3 (de)	2006-01-15	Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
DE60210139D1 (de)	2006-05-11	Pharmazeutische zusammensetzungen enthaltend tegaserod
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
IS7051A (is)	2003-11-26	Lyfjasamsetningar
DE60211183D1 (de)	2006-06-08	Pharmazeutische zusammensetzung enthaltend lumiracoxib
FI20022128A0 (fi)	2002-12-03	Farmaseuttinen koostumus
DE60217390D1 (de)	2007-02-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE366128T1 (de)	2007-07-15	Pharmazeutische zusammensetzung
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
ATE350029T1 (de)	2007-01-15	Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
NO20041236L (no)	2004-03-24	Farmasoytisk formulering
FI5468U1 (fi)	2002-07-30	Farmaseuttinen koostumus
SE0100847D0 (sv)	2001-03-09	Novel pharmaceutical composition
SE0102957D0 (sv)	2001-09-04	Pharmaceutical formulation
SE0103565D0 (sv)	2001-10-25	Pharmaceutical formulation
SE0102572D0 (sv)	2001-07-19	Pharmaceutical formulation
SE0102069D0 (sv)	2001-06-21	Pharmaceutical formulation
SE0101326D0 (sv)	2001-04-12	Pharmaceutical formulation